It will be more generic now, growth in A.I data will be better measured. It was too concentrated where underlying business and ability to close deals became an unfortunate afterthought.
The company wasn't making any money from Big Tech to justify the expenditure and LLM still not ready but Deep Learning applications is definitely an on going and growing factor in Enterprise.
- Forums
- ASX - By Stock
- APX
- Ann: Customer update and FY23 preliminary results
Ann: Customer update and FY23 preliminary results, page-218
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APX (ASX) to my watchlist
|
|||||
Last
50.0¢ |
Change
-0.005(0.99%) |
Mkt cap ! $111.5M |
Open | High | Low | Value | Volume |
51.0¢ | 53.0¢ | 49.0¢ | $1.034M | 2.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 25178 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.0¢ | 26979 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 25178 | 0.500 |
4 | 52371 | 0.495 |
15 | 360117 | 0.490 |
7 | 101980 | 0.485 |
10 | 470902 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.510 | 26979 | 3 |
0.515 | 15117 | 2 |
0.520 | 73197 | 6 |
0.525 | 20811 | 2 |
0.530 | 140339 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
APX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online